BG102638A - Таблети с високо съдържание на фамцикловир - Google Patents

Таблети с високо съдържание на фамцикловир

Info

Publication number
BG102638A
BG102638A BG102638A BG10263898A BG102638A BG 102638 A BG102638 A BG 102638A BG 102638 A BG102638 A BG 102638A BG 10263898 A BG10263898 A BG 10263898A BG 102638 A BG102638 A BG 102638A
Authority
BG
Bulgaria
Prior art keywords
phamcyclovir
tablets
increased
content
relates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
BG102638A
Other languages
English (en)
Other versions
BG63488B1 (bg
Inventor
Michael GREENWAY
Jennifer SLATER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis International Pharmaceutical Ltd
SmithKline Beecham PLC
Original Assignee
Novartis International Pharmaceutical Ltd
SmithKline Beecham PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis International Pharmaceutical Ltd, SmithKline Beecham PLC filed Critical Novartis International Pharmaceutical Ltd
Publication of BG102638A publication Critical patent/BG102638A/bg
Publication of BG63488B1 publication Critical patent/BG63488B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses

Abstract

Изобретението се отнася до фармацевтична таблета,която съдържа като активен компонент фамцикловирв количество повече от 85%.
BG102638A 1996-01-16 1998-07-15 Таблети с високо съдържание на фамцикловир BG63488B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9600847.9A GB9600847D0 (en) 1996-01-16 1996-01-16 Pharmaceuticals
PCT/EP1997/000195 WO1997025990A1 (en) 1996-01-16 1997-01-13 High-content famciclovir tablets

Publications (2)

Publication Number Publication Date
BG102638A true BG102638A (bg) 1999-07-30
BG63488B1 BG63488B1 (bg) 2002-03-29

Family

ID=10787105

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102638A BG63488B1 (bg) 1996-01-16 1998-07-15 Таблети с високо съдържание на фамцикловир

Country Status (38)

Country Link
US (1) US6765007B1 (bg)
EP (1) EP0874632B1 (bg)
JP (2) JP4711360B2 (bg)
KR (1) KR100338829B1 (bg)
CN (1) CN1132582C (bg)
AP (2) AP747A (bg)
AR (1) AR005456A1 (bg)
AT (1) ATE220910T1 (bg)
AU (1) AU713090B2 (bg)
BG (1) BG63488B1 (bg)
BR (1) BR9706982A (bg)
CY (1) CY2390B1 (bg)
CZ (1) CZ287205B6 (bg)
DE (1) DE69714215T2 (bg)
DK (1) DK0874632T3 (bg)
DZ (1) DZ2159A1 (bg)
EA (1) EA001946B1 (bg)
EG (1) EG23684A (bg)
ES (1) ES2180922T3 (bg)
GB (1) GB9600847D0 (bg)
HK (1) HK1016473A1 (bg)
HU (1) HU225472B1 (bg)
IL (1) IL124913A0 (bg)
MX (1) MX9805713A (bg)
MY (1) MY127527A (bg)
NO (1) NO315689B1 (bg)
NZ (1) NZ326769A (bg)
OA (1) OA10812A (bg)
PE (1) PE35498A1 (bg)
PL (1) PL187291B1 (bg)
PT (1) PT874632E (bg)
SK (1) SK282132B6 (bg)
TR (1) TR199800954T2 (bg)
TW (1) TW434016B (bg)
UA (1) UA63897C2 (bg)
UY (2) UY24437A1 (bg)
WO (1) WO1997025990A1 (bg)
ZA (1) ZA97310B (bg)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100136106A1 (en) * 2005-06-08 2010-06-03 Gary Liversidge Modified Release Famciclovir Compositions
AU2010265866B2 (en) 2009-06-26 2012-07-12 Taris Biomedical Llc Solid drug tablets for implantable drug delivery devices
JP2015063521A (ja) * 2013-09-02 2015-04-09 科研製薬株式会社 高い薬物含有率を有する錠剤及びその製造方法
CN104434852B (zh) * 2013-09-18 2018-11-20 北京韩美药品有限公司 泛昔洛韦直压片及其制备方法
CN112587491B (zh) * 2021-01-03 2022-08-23 迪沙药业集团有限公司 一种泛昔洛韦片组合物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421800C1 (de) * 1984-06-12 1986-04-17 Maschinen und Werkzeugbau Michael Brümmer GmbH, 8804 Dinkelsbühl Elastische Walze zum Behandeln einer thermoplastischen Folie
EP0182024B1 (en) 1984-09-20 1991-04-03 Beecham Group Plc Purine derivatives and their pharmaceutical use
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
KR100245252B1 (ko) 1991-05-15 2000-03-02 도로시 케이. 로빈슨 간에 의해 대사될 수 있는 프로드럭의 결정 및 그의 치료학적 용도
GB9303157D0 (en) * 1993-02-17 1993-03-31 Scotia Holdings Plc Treatment of a group of related disorders
IL111138A (en) 1993-10-05 1997-04-15 Smithkline Beecham Plc Pharmaceutical compositions comprising penciclovir and/or its bioprecursor and/or its derivatives for the treatment and prophylaxis of post-herpetic neuralgia
JP3702594B2 (ja) * 1997-08-07 2005-10-05 株式会社明電舎 パラメータ調節方法及び装置

Also Published As

Publication number Publication date
HK1016473A1 (en) 1999-11-05
AP9801298A0 (en) 1998-09-30
EP0874632B1 (en) 2002-07-24
SK282132B6 (sk) 2001-11-06
CZ225498A3 (cs) 1998-12-16
CN1132582C (zh) 2003-12-31
AR005456A1 (es) 1999-06-23
MY127527A (en) 2006-12-29
AP1114A (en) 2002-10-18
HU225472B1 (en) 2006-12-28
PT874632E (pt) 2002-10-31
AP747A (en) 1999-05-03
AP9700911A0 (en) 1997-01-31
PE35498A1 (es) 1998-08-07
ZA97310B (en) 1997-10-23
AU1541897A (en) 1997-08-11
BR9706982A (pt) 1999-07-20
HUP9901021A3 (en) 2000-08-28
JP4711360B2 (ja) 2011-06-29
SK95698A3 (en) 1999-01-11
MX9805713A (es) 1998-10-31
NO315689B1 (no) 2003-10-13
CN1208350A (zh) 1999-02-17
DE69714215T2 (de) 2003-01-23
TR199800954T2 (xx) 1998-10-21
KR100338829B1 (ko) 2002-07-18
DK0874632T3 (da) 2002-11-11
AU713090B2 (en) 1999-11-25
PL327922A1 (en) 1999-01-04
EA001946B1 (ru) 2001-10-22
WO1997025990A1 (en) 1997-07-24
GB9600847D0 (en) 1996-03-20
CY2390B1 (en) 2004-09-10
ATE220910T1 (de) 2002-08-15
NZ326769A (en) 2000-05-26
EG23684A (en) 2007-05-09
JP2000503311A (ja) 2000-03-21
DE69714215D1 (de) 2002-08-29
ES2180922T3 (es) 2003-02-16
UY24437A1 (es) 1997-06-06
EA199800573A1 (ru) 1999-02-25
UA63897C2 (en) 2004-02-16
DZ2159A1 (fr) 2002-12-01
TW434016B (en) 2001-05-16
NO983259D0 (no) 1998-07-15
HUP9901021A2 (hu) 1999-08-30
UY24556A1 (es) 2001-08-27
KR19990077229A (ko) 1999-10-25
IL124913A0 (en) 1999-01-26
EP0874632A1 (en) 1998-11-04
JP2009091362A (ja) 2009-04-30
OA10812A (en) 2003-01-29
BG63488B1 (bg) 2002-03-29
CZ287205B6 (en) 2000-10-11
US6765007B1 (en) 2004-07-20
NO983259L (no) 1998-07-15
PL187291B1 (pl) 2004-06-30

Similar Documents

Publication Publication Date Title
HUP0003305A3 (en) Hiv protease inhibiting tetrahydro-pyrimid-2-on derivative, pharmaceutical compositions containing it and process for producing the compound
DE60018100D1 (en) Polymorphe form von atorvastatin-calcium
ZA964337B (en) Pharmaceutical compositions containing irbesartan.
AP1450A (en) Solid oral dosage form comprising a combination of metformin and glibenclamide.
MX9602683A (es) Compuestos de 6-dimetilaminometil-1-fenil-ciclohexano como substancias farmaceuticamente activas.
BG106030A (bg) Фармацевтичен състав
GB9410987D0 (en) High dosage pharmaceutical compositions
PH31059A (en) Pharmaceutical compositions comprising cyclosporins.
MX9709238A (es) Formulaciones farmaceuticas y de dieta para la profilaxis y tratamiento de trastornos gastrointestinales.
ZA968956B (en) Substituted 2,4-imidazolidinedione compounds as pharmaceutical active ingredients
PL309282A1 (en) Application of 2-amino-6-n-propyl-amino- 4,5,6,7-tetrahydrobenzothiasole (pramipexol) as an antidepressant
HK1029060A1 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
IL117091A0 (en) Methylphenyloxazolidinone derivatives pharmaceutical compositions containing the same and processes for the preparation thereof
AU2924699A (en) Tryptase inhibitors
BG102589A (bg) 3-азетидинилалкилпиперидини или - пиролидини катотахикининови антагонисти
ZA961138B (en) Solid active ingredient compositions containing hydroxypropylcellulose.
BG102667A (bg) Състав, съдържащ диосгенин
BG102638A (bg) Таблети с високо съдържание на фамцикловир
ZA979647B (en) Heterocyclic compounds, compositions and uses.
EP0427124A3 (en) Antacid tablets
IL105276A (en) (S)-a-PHENYL- 2-PYRIDINEETHANAMINE, ITS PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
CA2185242A1 (en) Sustained release tablet containing diclofenac-na
ZA92110B (en) Pharmaceutical compositions.
AU3580995A (en) Derivatives of carbohydrates and compositions containing them
AU6849198A (en) Neurotrypsin